NDS Updates

A meeting of the National Drug Scheduling Advisory Committee (NDSAC) was held on June 1, 2025, with the following interim recommendations made: Any objections to these interim recommendations must be […]

The next meeting of the National Drug Scheduling Advisory Committee (NDSAC) is scheduled for June 1, 2025. The primary purpose of the meeting is to consider the following matter: Interested

The proposed meeting of the National Drug Scheduling Advisory Committee (NDSAC) for March 23-24, 2025 is cancelled. The next meeting of the Committee is scheduled for June 1-2, 2025. The

The interim recommendations made by the National Drug Scheduling Advisory Committee (NDSAC) on December 2, 2024 that: **Note: 8.5 mg of cetirizine base is approximately equivalent to 10 mg of

A meeting of the National Drug Scheduling Advisory Committee (NDSAC) was held on December 2, 2024, with the following interim recommendations made: **Note: 8.5 mg of cetirizine base is approximately

The interim recommendation made by the National Drug Scheduling Advisory Committee (NDSAC) on September 15, 2024 that: was finalized effective November 5, 2024. Final approval of the interim recommendation was

The next meeting of the National Drug Scheduling Advisory Committee (NDSAC) is scheduled for December 2, 2024. The primary purpose of the meeting is to consider the following matter: Interested

A meeting of the National Drug Scheduling Advisory Committee (NDSAC) was held on September 15, 2024, with the following interim recommendation made: Any objections to this interim recommendation must be

The following are the tentative meeting dates for the National Drug Scheduling Advisory Committee (NDSAC) in 2025. https://www.napra.ca/national-drug-schedules/ndsac-meetings/

The interim recommendations made by the National Drug Scheduling Advisory Committee (NDSAC) on June 2, 2024 that: were finalized effective July 23, 2024. Final approval of the interim recommendations was